Mrs. Acbay has more than 34 years of biotechnology and pharmaceutical experience and over 29 years in Regulatory Affairs and Drug Development Leadership experience and has led successful clinical development and registration of multiple transformative medicines. Prior to joining ReAlta, she served as the VP of Regulatory Affairs and Quality Assurance at NGM Biopharmaceuticals (NGM). At NGM she was responsible for the development of their early and late-stage pipeline. She began her career at Genentech Inc where she was a Cell Culture Bioprocess Technician, and in Manufacturing Sciences then to Regulatory Affairs as a Scientist. She continued her global regulatory experience and Global Quality Management site inspections with increasing regulatory operations, drug development roles and responsibilities in drug approvals and successful product launches at Gilead Sciences, Actelion Pharmaceuticals (acquired by J&J), and Nektar Therapeutics. She has strong scientific and regulatory expertise in successful early and late-stage drug development and commercialization including in immuno-oncology, rare diseases, pulmonology, oncology, cardiovascular, infectious diseases, anti-virals, ophthalmology, metabolic diseases, hepatology and women’s health. In 2014 she received the Healthcare Businesswoman’s Association (HBA) Rising Star Award and was a member of CHIEF, a private network focused on women executive leaders. Mrs. Acbay has earned an Honors Bachelor of Science from Notre Dame de Namur University in Belmont CA, and an Executive Professional Credential from Stanford Graduate School of Business in Palo Alto, CA.
Back to Team